Research & Clinical Trial News
Understanding KAT6 and Its Role in Breast Cancer
KAT6 refers to a protein called lysine acetyltransferase 6 (KAT6A), which is involved in the control of gene activity in cells. KAT6 plays a key role in breast cancers that depend on estrogen [estrogen receptor (ER) positive breast cancers].
Read More
Understanding GDF15 and Its Role in Cancer‑Related Weight Loss
Weight loss and muscle wasting in cancer are more than just side effects of the disease. They can shorten survival, reduce energy, and make it harder for patients to receive or recover from treatments. Current options to slow or reverse this decline are limited. Research over the past decade has made it clear that GDF15 is one of the main triggers of appetite loss and wasting in cancer.
Read More
Astera Cancer Care Enrolls First Patient as First Community Site in Pioneering Clinical Trial
Astera Cancer Care is proud to announce that we have enrolled our first patient in a groundbreaking first-in-human (FIH) clinical trial, becoming the first community site in the United States to do so.
Read More
First Patient in the World Enrolled in IDeate-Lung02 Trial
Astera Cancer Care, an independent, physician-owned multi-specialty oncology practice, has yet again achieved another significant milestone by enrolling the world’s first patient in phase 3 of the IDeate-Lung02 clinical trial.
Read More
Astera Cancer Care Introduces ALPHA3 Clinical Trial
Astera Cancer Care has collaborated with Allogene Therapeutics to revolutionize the landscape of CAR T cell therapy, particularly for patients with Large B-Cell Lymphoma (LBCL).
Read More